Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency ...

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

Over 360 yrs after Shivaji Maharaj outsmarted Mughal army at the Battle of Umbarkhind, engineers are building India’s tallest ...

Daniel Ives You can reverse the age of cells all the way down to zero in just a few weeks. So you can actually take a ...

Barclays 23rd Annual Global Technology Conference December 11, 2025 12:50 PM ESTCompany ParticipantsDaniel Lentz - Chief ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

NEET UG 2026 is expected to witness intense competition, making NCERT-based preparation more crucial than ever for aspirants aiming for top medical colleges. Since the Biology section carries 90 ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...